Armstrong Economics Blog/Corruption Re-Posted Oct 27, 2022 by Martin Armstrong
Our computer indicated that Pfizer was heading down. They’ve already convinced or coerced everyone eligible to take the vaccines. Those who have held out are unlikely ever to accept the vaccine at this point. Only 5% of those eligible in the US received a booster shot as skepticism is rising. Numerous studies have revealed the hidden dangers of the vaccine. Transmission and infection are still possible with the vaccination, eliminating the intended purpose. A Pfizer representative recently admitted that they never even tested the potion for transmission. Worse, new studies determined that the vaccine produces a negative effect and makes people more susceptible to COVID. There is no medical basis for taking them.
Still, there are those who will line up to receive another booster. To compensate for the lack of willing participants, Pfizer announced plans to quadruple the price of its COVID vaccine. Pfizer will now charge around $110 to $130 per dose, and this comes at a cost to governments who are willingly paying to distribute the poison to the public. The US government helped Pfizer create the vaccine under Operation Warpspeed by providing them with billions in funding.
“We are confident that the U.S. price point of the COVID-19 vaccine reflects its overall cost effectiveness and ensures the price will not be a barrier for access for patients,” Pfizer executive Angela Lukin said. The US was previously paying around $30 per jab. Coincidentally, once the COVID emergency order ends, private insurance companies will be forced to pay the increased price for a faulty product. Lukin believes the private sector will not take over the bill until Q1 2023 “at the earliest.” It will be interesting to see if insurance companies are willing to eat the cost of the vaccine. More than likely, they will expect some incentive from doing so, or Pfizer and others will offer some rebate program funded by the government that continues to support this agenda.